Antiviral Chemistry and Chemotherapy
SJR0.230
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.230 | Q4 | 33.5% | |
| 2024 | — | — | 0.325 | Q3 | 48.2% | |
| 2023 | — | — | 0.369 | Q3 | 55.1% | |
| 2022 | — | — | 0.518 | Q2 | 67.4% | |
| 2021 | — | — | 0.844 | Q1 | 82.6% | |
| 2020 | — | — | 0.919 | Q1 | 83.4% | |
| 2019 | — | — | 0.597 | Q2 | 72.5% | |
| 2018 | — | — | 0.349 | Q3 | 54.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
0956-3202
ISSN
2040-2066
region
Western Europe
coverage
1990-2015, 2017-2023